Skip to content
Company Analysis

Delcath Systems, Inc. DCTH

A comprehensive view of key metrics, scores, and financial health for Delcath Systems, Inc.

Overview of Delcath Systems, Inc.

DCTH NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
Delcath Systems, Inc. (DCTH), is a Small Cap company, in the Medical Devices industry, last closed at $14.29, about 75.2% overvalued vs fair value, +65.4% 1Y return, placing in the top 10% of its sector.
Metrics P/E 134.0× Rev Growth 129.1% ROE 3.0% Gross Margin 86.2%
USD 14.29
1.78%
(Delayed)
• Vol 90d: 52.4%
52-Week Range
Market Cap
$495.80M
Enterprise Value
$448.28M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Good
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Good
Completeness: 76%
Confidence: 89%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.delcath.com
HQ New York, NY
Employees 96
Fiscal year Dec 31

Next Events

Earnings Nov 9 Call: Nov 9

Fair Value Snapshot

Bear Base Bull
$3
$4
$4
Current: $14.29 -75% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$85.2M
129.1%%
Gross Profit
$73.4M
136.8%%
Operating Income (GAAP)
$660.0K
105.3%%
EBITDA
$1.0M
108.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
86.2%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
0/3
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Delcath Systems, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
71
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.97). High FCF conversion confirms strong earnings quality.
  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.94). This signals strong consumable attach-rate economics.

Key risks

  • Thin Interest Coverage Interest coverage lags peers (score 0.09). Thin coverage limits M&A optionality and raises refinancing risk.
  • Declining Capital Returns ROIC durability is weak (score 0.19). Volatility or decline in returns is a leading moat erosion signal.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
69
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 95% Coverage
Trade-Off Triangle Visualization A ternary plot showing DCTH's balance between Growth (38.3%), Profitability (33.2%), and Safety (28.5%). Growth 38% Safety 29% Profitability 33%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

95th percentile vs peers
95
Key Signals
Rev Growth YoY 1.29 96p Revenue CAGR 3Y 2.15 96p EPS Growth YoY 1.08 91p TSR 80.8% 93p Asset Growth YoY 61.4% 91p
Strengths
  • Growth performance in top 20% of peers (percentile: 95)
  • Rev Growth YoY in top 20% of peers (1.29, 96th percentile)
  • Revenue CAGR 3Y in top 20% of peers (2.15, 96th percentile)
  • EPS Growth YoY in top 20% of peers (1.08, 91th percentile)
Risks

No significant risks identified for this axis.

Profitability

82th percentile vs peers
82
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

70th percentile vs peers
71
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Delcath Systems, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$3.54
- - -
-75.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000